Infusion pump, insulin, ambulatory
Access comprehensive regulatory information for Infusion pump, insulin, ambulatory in the Australia medical device market through Pure Global AI's free TGA ARTG database. This Class IIb is sponsored by Ypsomed Australia Pty Ltd, manufactured by Ypsomed AG in Switzerland. The device registration started on August 17, 2017.
This page provides complete registration details including sponsor information, manufacturer details, and regulatory compliance data from the official Australia TGA ARTG medical device database. Pure Global AI offers free access to Australia's complete medical device registry with 131,000+ devices, helping global MedTech companies navigate TGA regulations efficiently.
A device that provides continuous subcutaneous delivery of insulin to individuals with insulin-dependent (type I) diabetes. It may also be used for intermittent delivery to treat non-insulin-dependent (type II) and pregnancy-induced diabetes.